Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden

Caregivers Clinical Trial

Official title:

Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02250911
• Other study ID #: 14-208
• Status: Completed
• Phase: N/A
• Start date: September 2014
• Est. completion date: August 2018

Study information

• Verified date: August 2018
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to gather information on how easy it is to implement the workshop, as well as whether individuals find this workshop helpful. In this study, participants will be assigned at random to one of the two study groups. Based on the information we obtain, we hope to develop an easily accessible support service for caregivers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 88
• Est. completion date: August 2018
• Est. primary completion date: August 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• As per self report, a current caregiver to a patient with any site or stage of cancer

• Age 18 or over

• A score of > 4 on the Distress Thermometer (DT) and indication that this distress is related in some way to the caregiving role

• In the judgment of the investigators and/or consenting professional, able to comprehend English to complete study assessments

• Able to perform informed consent

• Enrollment is open to caregivers with their own current/past cancer histories

Exclusion Criteria:

• Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent.

• As per self report, unable to access a computer with Internet or unable to use a computer with Internet provided by the study

• Participated in the development and refinement of the CCC Workshop (prospective exemption X14-006)

Related Conditions & MeSH terms

• Caregivers

Intervention

Other:
• webcasts

Behavioral:
• Assessments

Other:
• Usual care

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	American Cancer Society, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	feasibility of this novel approach	which will be measured by our ability to recruit our target sample and the proportion of participants who complete the CCC Workshop. Additional indices related to this aim (acceptability) will be gathered via both quantitative (entire sample) and qualitative (with a subset of participants randomized to received the CCC Workshop) methods.	2 years

External Links

•   Memorial Sloan Kettering Cancer Center